Investment Analysts’ updated eps estimates for Monday, August 14th:

Ameresco (NYSE:AMRC) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $7.50 target price on the stock. According to Zacks, “Ameresco, Inc. is an independent provider of comprehensive energy efficiency solutions for facilities throughout North America. The Company’s solutions include upgrades to a facility’s energy infrastructure, and the construction and operation of renewable energy plants. It engages in the development, design, engineering, and installation of projects that reduce the energy, as well as operation and maintenance costs of governmental, educational, utility, healthcare, and other institutional, commercial, and industrial entities facilities. Ameresco, Inc. is headquartered in Framingham, Massachusetts. “

American Software (NASDAQ:AMSWA) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “American Software Inc., through its subsidiaries, develops, markets and supports a portfolio of application software solutions that enable businesses to respond to today’s dynamic global marketplace. The company’s software and services solutions are designed to automate many planning and operational functions principally in the areas of: (i) Enterprise Resource Planning (ERP), (ii) Flow Manufacturing, (iii) E-Commerce Solutions and (iv) Logility Value Chain Solutions(TM). The company’s products are designed to provide rapid return on investment. “

Aptose Biosciences (NASDAQ:APTO) (TSE:APS) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $1.50 price target on the stock. According to Zacks, “Aptose Biosciences Inc. is a clinical-stage biotechnology company. The company is advancing therapeutics to treat life-threatening cancers, such as acute myeloid leukemia, high-risk myelodysplastic syndromes and other hematologic malignancies. Its lead program APTO-253 has completed a Phase 1 study in patients with solid tumors. Aptose Biosciences Inc., formerly known as Lorus Therapeutics Inc., is headquartered in Toronto, Canada. “

Arch Therapeutics (NASDAQ:ARTH) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Arch Therapeutics, Inc. is a medical device company. It develops products that make surgery and interventional care faster and safer by using an approach to stop bleeding, control leaking, and provide other advantages during surgery and trauma care. The Company’s lead product candidate includes AC5 (TM), a biocompatible synthetic peptide, to achieve hemostasis in minimally invasive and open surgical procedures. Arch Therapeutics, Inc. is headquartered in Wellesley, Massachusetts. “

Ascent Capital Group (NASDAQ:ASCMA) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Ascent Capital Group, Inc. is a holding company and its assets primarily consist of its wholly-owned subsidiary, Monitronics International, Inc. The Company provides security alarm monitoring and related services to residential and business subscribers throughout the United States and parts of Canada. Monitronics monitors signals arising from burglaries, fires and other events through security systems at subscribers’ premises. Ascent Capital Group, Inc., formerly known as Ascent Media Corporation, is based in Englewood, Colorado. “

Cempra (NASDAQ:CEMP) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Cempra Holdings, LLC is a pharmaceutical company engaged in developing antibiotics for the treatment of bacterial infectious diseases. It focuses on developing antibiotics for treating respiratory tract, skin and skin structure infections and to target the growing problem of antimicrobial resistance. Cempra Holdings, LLC is headquartered in Chapel Hill, North Carolina. “

Clipper Realty (NASDAQ:CLPR) was downgraded by analysts at Zacks Investment Research from a buy rating to a sell rating. According to Zacks, “Clipper Realty Inc. is a real estate investment trust. The Company specializes in acquiring, owning, repositioning, operating and managing asset. Clipper Realty Inc. is headquartered in Brooklyn, New York. “

CU Bancorp (CA) (NASDAQ:CUNB) had its buy rating reaffirmed by analysts at Piper Jaffray Companies. The firm currently has a $42.00 target price on the stock.

DineEquity (NYSE:DIN) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “IHOP Corp. develops, franchises and operates International House of Pancakes restaurants. IHOP restaurants feature moderately-priced, high-quality food and beverage items, and table service in an attractive and comfortable atmosphere. Although IHOP restaurants are best known for their award-winning pancakes, omelets and other breakfast specialties, IHOP restaurants are open throughout the day and evening hours and offer a broad array of lunch, dinner and snack items as well. “

Ellie Mae (NASDAQ:ELLI) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $100.00 price target on the stock.

Home Depot, Inc. (The) (NYSE:HD) had its buy rating reiterated by analysts at Longbow Research. The firm currently has a $175.00 target price on the stock.

Ionis Pharmaceuticals (NASDAQ:IONS) had its buy rating reissued by analysts at Laidlaw. Laidlaw currently has a $65.00 price target on the stock.

J.C. Penney Company, Inc. Holding (NYSE:JCP) had its buy rating reiterated by analysts at Northcoast Research. Northcoast Research currently has a $9.00 target price on the stock.

Lowe’s Companies (NYSE:LOW) had its buy rating reaffirmed by analysts at Longbow Research. The firm currently has a $95.00 target price on the stock.

Micron Technology (NASDAQ:MU) had its overweight rating reissued by analysts at Morgan Stanley. The firm currently has a $36.00 target price on the stock.

Mulesoft (NASDAQ:MULE) had its buy rating reiterated by analysts at Piper Jaffray Companies. The firm currently has a $27.00 target price on the stock.

Asante Solutions (NASDAQ:PUMP) had its buy rating reissued by analysts at Piper Jaffray Companies. They currently have a $14.00 target price on the stock.

Shoe Carnival (NASDAQ:SCVL) had its outperform rating reiterated by analysts at Wedbush. They currently have a $21.00 price target on the stock.

Steven Madden (NASDAQ:SHOO) had its outperform rating reaffirmed by analysts at Wedbush. The firm currently has a $48.00 target price on the stock.

Smart Sand (NYSE:SND) had its buy rating reissued by analysts at Piper Jaffray Companies.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.